Is Stryker (STR) a good stock to buy?
Stryker has received a consensus rating of Buy. The company's average rating score is 2.57, and is based on 13 buy ratings, 7 hold ratings, and 1 sell rating. According to analysts' consensus price target of $293.85, Stryker has a forecasted upside of 11.4% from its current price of $263.85.
Is Stryker’s pricing pressure a concern?
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern. © 2022 Yahoo. All rights reserved.
How do Stryker employees rate the CEO of the company?
1,492 employees have rated Stryker CEO Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among Stryker's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. Who are some of Stryker's key competitors?
What does Stryker Corporation do?
Analyst Report: Stryker Corp. Based in Kalamazoo, Michigan, Stryker manufactures and markets medical devices, primarily in the orthopedic market. The Orthopedics segment sells joint reconstructive products (hips, knees and shoulders) and trauma implants.
See more
Is Stryker stock a good buy?
Stryker has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 12 buy ratings, 8 hold ratings, and no sell ratings.
Will Stryker stock go up?
The 21 analysts offering 12-month price forecasts for Stryker Corp have a median target of 250.00, with a high estimate of 297.00 and a low estimate of 205.00. The median estimate represents a +25.34% increase from the last price of 199.46.
Will Stryker shares split?
Stryker (SYK) has 5 splits in our Stryker stock split history database....SYK Split History TableDateRatio05/17/20042 for 14 more rows
Who owns the most Stryker stock?
The Vanguard Group, Inc.Top 10 Owners of Stryker CorpStockholderStakeShares ownedThe Vanguard Group, Inc.7.29%27,547,822Greenleaf Asset Management, Inc.5.57%21,048,539T. Rowe Price Associates, Inc. (I...5.33%20,161,223Wellington Management Co. LLP4.07%15,370,3916 more rows
Is Stryker overvalued?
Is Stryker still cheap? The stock is currently trading at US$254 on the share market, which means it is overvalued by 27% compared to my intrinsic value of $199.63.
How do I invest in Stryker?
How to buy Stryker Stocks & Shares to Invest in SYK Steps of buying Stryker sharesStep 1: find a good online broker. ... Step 2: open your brokerage account. ... Step 3: deposit money to your account. ... Step 4: buy the Stryker share. ... Step 5: review your Stryker position regularly.
Who is Stryker owned by?
Ronda Stryker is a director of Stryker Corp., the medical equipment company founded by her grandfather, Homer Stryker (d. 1980). She owns about 6% of Stryker Corp.
Should I buy or sell Stryker stock right now?
18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 6 hold ra...
What is Stryker's stock price forecast for 2022?
18 Wall Street analysts have issued 1-year target prices for Stryker's stock. Their forecasts range from $275.00 to $320.00. On average, they expec...
How has Stryker's stock price performed in 2022?
Stryker's stock was trading at $267.42 at the beginning of 2022. Since then, SYK stock has decreased by 19.1% and is now trading at $216.40. View...
When is Stryker's next earnings date?
Stryker is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022. View our earnings forecast for Stryker .
How were Stryker's earnings last quarter?
Stryker Co. (NYSE:SYK) released its quarterly earnings results on Thursday, April, 28th. The medical technology company reported $1.97 EPS for the...
How often does Stryker pay dividends? What is the dividend yield for Stryker?
Stryker declared a quarterly dividend on Wednesday, May 4th. Investors of record on Thursday, June 30th will be given a dividend of $0.695 per shar...
Is Stryker a good dividend stock?
Stryker(NYSE:SYK) pays an annual dividend of $2.78 per share and currently has a dividend yield of 1.28%. Stryker has been increasing its dividend...
What guidance has Stryker issued on next quarter's earnings?
Stryker updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $9.60-$9.60 for the period, compared to the...
Who are Stryker's key executives?
Stryker's management team includes the following people: Mr. Kevin A. Lobo , Chairman, CEO & Pres (Age 57, Pay $3.59M) ( LinkedIn Profile ) Mr....
Is Stryker stock a Buy, Sell or Hold?
Stryker stock has received a consensus rating of buy. The average rating score is and is based on 34 buy ratings, 7 hold ratings, and 1 sell ratings.
What was the 52-week low for Stryker stock?
The low in the last 52 weeks of Stryker stock was 214.39. According to the current price, Stryker is 100.94% away from the 52-week low.
What was the 52-week high for Stryker stock?
The high in the last 52 weeks of Stryker stock was 281.12. According to the current price, Stryker is 76.98% away from the 52-week high.
What are analysts forecasts for Stryker stock?
The 42 analysts offering price forecasts for Stryker have a median target of 273.81, with a high estimate of 315.00 and a low estimate of 215.00. T...
When is Stryker's dividend?
What is Stryker Corporation?
This represents a $2.52 annualized dividend and a yield of 0.97%. The ex-dividend date is Tuesday, June 29th.
New York Stock Exchange
Stryker Corporation operates as a medical technology company . The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Environmental, Social, and Governance Rating
A medical technology company in orthopaedics products. Its products include implants, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
How to calculate restricted stock?
A medical technology company in orthopaedics products. Its products include implants, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation.
How long are futures trading delayed?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
